HOME › DRUGS › DABRAFENIB
ACTIVE SUBSTANCE / INN

DABRAFENIB

Brand name(s): Tafinlar, Finlee
EMA LISTED
AUTHORISED
Glioma
Melanoma
ACTIVE SUBSTANCE
Dabrafenib
REGULATORS
EMA
SPONSORS / MAH
Novartis Europharm Limited
TOTAL APPLICATIONS
2
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
FinleeNovartis Europharm LimitedAuthorised15/11/2023Glioma
TafinlarNovartis Europharm LimitedAuthorised26/08/2013Melanoma

FULL INTELLIGENCE ON DABRAFENIB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →